Physician profile
Lee Scott Bloemendal
NPI 1790700524
$10,421.01
in general payments reported to CMS, 2019-2025
11 companies · $70.39 in 2025
The $70.39 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,637 · 2020: $512 · 2021: $995 · 2022: $55.94 · 2023: $1,625 · 2024: $5,525 · 2025: $70.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,150 · Travel and Lodging: $1,757 · Food and Beverage: $1,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,150.00 |
| Travel and Lodging | $1,756.86 |
| Food and Beverage | $1,313.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,661.67 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $1,814.49 | 2023-2025 | Phasix Mesh |
| Medtronic, INC. | $260.24 | 2024 | Endurant Iis, Ligasure, Signia |
| Acell, INC. | $260.06 | 2019-2020 | |
| Ethicon US, LLC | $149.99 | 2019-2025 | Harmonic |
| Integra Lifesciences Corporation | $132.38 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Stryker Corporation | $46.85 | 2019 | |
| Endogastric Solutions, INC | $39.39 | 2020 | |
| Allergan, INC. | $24.76 | 2022 | |
| Baxter Healthcare | $19.27 | 2019 | |
| Medical Device Business Services, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Bloemendal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.